Locally, trials and studies need first to be reviewed by the Cambridge BRC/Covid-19 oversight committee before being submitted through the national NIHR prioritisation mechanism. 

All COVID-19-related research studies are being prioritised at a national level through the NIHR.  Studies seeking approval should first apply through the NIHR gateway, with nationally prioritised research being signposted for an expedited regulatory approval with the HRA/MHRA.

More information about undertaking COVID-19-based research studies at CUH can be found at Covid19research@addenbrookes.nhs.uk.